GPCR
Structure Therapeutics Inc.
32.70$
-6.8%
vs. previous close
Closing price · As of: Sep 29, 2026
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | -100.0% | – | – | – | -100.0% | – | – | – | – | – | – | |
| – | -20.0% | +134.6% | -64.8% | +15.3% | – | – | +24.3% | – | – | – | – | – | |
| – | – | -162.8% | – | – | – | -177.1% | – | – | – | – | – | – | |
| – | +14.4% | +3.2% | +6.6% | +47.8% | +2.7% | +28.0% | +27.6% | +7.8% | +16.4% | -2.9% | +50.0% | – | |
| – | +26.9% | +3.5% | -0.6% | +17.5% | +2.5% | -1.0% | +17.1% | -6.0% | +18.7% | +30.2% | -18.8% | – | |
| – | +18.5% | +3.3% | +4.1% | +37.6% | +2.7% | +19.7% | +25.1% | +4.7% | -132.5% | – | +34.2% | – | |
| – | – | – | – | – | – | – | – | – | – | -473.7% | – | – | |
| – | +239.0% | -37.3% | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | -329.1% | – | – | |
| – | -177.0% | – | +82.8% | +73.6% | +47.8% | -27.9% | +41.8% | -22.3% | +57.4% | +12.1% | +22.8% | – | |
| – | – | – | – | – | – | – | – | – | – | -330.9% | – | – | |
| – | – | – | – | – | – | – | – | – | – | -322.7% | – | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: September 29, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.